Miss Shijin Suo
Higher Degree by Research Candidate
School of Pharmacy and Biomedical Sciences
College of Health
I am a PhD student at the University of Adelaide, currently working in the laboratory of Professor Andrea Yool. My research focuses on developing novel approaches to monitor and inhibit glioblastoma (GBM) cell invasion. Specifically, my project explores the use of the voltage-sensitive dye BeRST 1 to image real-time membrane potential responses in GBM cells. This work aims to identify the mechanisms of action of small-molecule compounds that inhibit GBM invasion, providing new insights into non-cytotoxic therapeutic strategies.I completed my Honours degree in 2024 with First Class Honours in the laboratory of Associate Professor Michael Lardelli. My Honours project investigated whether zebrafish are capable of producing amyloid beta (Aβ) protein, contributing to the evaluation of zebrafish as a model for Alzheimer's disease research.My research interests span cancer cell electrophysiology, neuro-oncology, and imaging technologies for therapeutic screening.
| Language | Competency |
|---|---|
| Chinese (Cantonese) | Can speak and understand spoken |
| Chinese (Mandarin) | Can read, write, speak and understand spoken |
| English | Can read, write, speak and understand spoken |
| Date | Institution name | Country | Title |
|---|---|---|---|
| University of Adelaide | Australia | Bachelor of Science (Honours) | |
| University of Adelaide | Australia | Bachelor of Science (Biomedical Science) |
| Year | Citation |
|---|---|
| 2026 | Wagner, K. K., Fotiou, M., Suo, S. J., Ramesh, S. A., Davis, R. A., & Yool, A. J. (2026). Semisynthetic indole alkaloids restrain the invasiveness of glioblastoma cell lines and inhibit human Aquaporin-1 water channels. Biochemical Pharmacology, 244, 117613-1-117613-16. WoS1 |
| 2023 | Gerken, E., Ahmad, S., Rattan, L., Hemsley, K., Allen, A., Allen, A., . . . Lardelli, M. (2023). Zebrafish models of Mucopolysaccharidosis IIIA, IIIB, and IIIC show hyperactivity, neuroinflammation and changes in oligodendrocyte cell state. Europe PMC3 |